Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.24.2.u1
Condensed Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 3,086,455 $ 9,165,179
Marketable securities 4,853,559 4,086,873
Prepaid research and development 306,300 219,817
Prepaid expenses and other current assets 356,487 739,179
Total current assets 8,602,801 14,211,048
Equipment and improvements, net 60,235 73,372
Right-of-use asset 163,762 222,227
Total assets 8,826,798 14,506,647
Current liabilities:    
Accounts payable 1,340,538 646,767
Lease obligation, current 152,224 150,095
Accrued expenses and other current liabilities 2,034,525 2,259,955
Insurance premium financing payable 177,256 381,784
Total current liabilities 3,704,543 3,438,601
Lease obligation, net of current portion 25,606 90,124
Total liabilities 3,730,149 3,528,725
Commitments and contingencies (see Note 13)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 7,216,145 and 6,186,280 shares issued and outstanding at June 30, 2024 and December 31, 2023 7,216 6,186
Additional paid-in capital 81,600,425 77,871,584
Accumulated other comprehensive (loss) income (1,024) 877
Accumulated deficit (76,509,968) (66,900,725)
Total stockholders' equity 5,096,649 10,977,922
Total liabilities and stockholders' equity $ 8,826,798 $ 14,506,647